<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01082172</url>
  </required_header>
  <id_info>
    <org_study_id>771-0001 TAA Trial</org_study_id>
    <nct_id>NCT01082172</nct_id>
  </id_info>
  <brief_title>South American Thoracic Stent-Graft Study</brief_title>
  <official_title>A Pilot Trial to Evaluate the Performance of the TriVascular Thoracic Stent Graft System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TriVascular, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Endologix</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, non-randomized multi-center clinical evaluation of the performance of the&#xD;
      TriVascular Thoracic Stent Graft System when used in the treatment of subjects with thoracic&#xD;
      aortic aneurysms (TAA).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Absence of device-related serious adverse events within 30-days of endovascular procedure</measure>
    <time_frame>30-Days</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">2</enrollment>
  <condition>Thoracic Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Thoracic Stent Graft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Thoracic Stent Graft implanted device</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implant Thoracic Stent Graft</intervention_name>
    <description>Endovascular implant of Thoracic Aortic Aneurysm Stent Graft</description>
    <arm_group_label>Thoracic Stent Graft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The TriVascular Thoracic Stent Graft System is indicated in subjects diagnosed with an&#xD;
             aneurysm in the descending thoracic aorta having vascular morphology suitable for&#xD;
             endovascular repair, including:&#xD;
&#xD;
               -  Adequate iliac/femoral access compatible with the required delivery systems,&#xD;
&#xD;
               -  Non-aneurysmal aortic segments proximal and distal to the aneurysm.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Pontificia Universidad Caolica de Chile</name>
      <address>
        <city>Santiago</city>
        <country>Chile</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Chile</country>
  </location_countries>
  <removed_countries>
    <country>Brazil</country>
  </removed_countries>
  <link>
    <url>http://www.TriVascular.com</url>
    <description>TriVascular Website</description>
  </link>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 4, 2010</study_first_submitted>
  <study_first_submitted_qc>March 5, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2010</study_first_posted>
  <last_update_submitted>March 4, 2021</last_update_submitted>
  <last_update_submitted_qc>March 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thoracic</keyword>
  <keyword>aortic</keyword>
  <keyword>aneurysm</keyword>
  <keyword>TAA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Thoracic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

